Apolipoprotein E Polymorphism and Left Ventricular Failure in Beta-Thalassemia: A Multivariate Meta-Analysis.
Niki L DimouKaterina G PantavouPantelis G BagosPublished in: Annals of human genetics (2017)
Apolipoprotein E (ApoE) is potentially a genetic risk factor for the development of left ventricular failure (LVF), the main cause of death in beta-thalassemia homozygotes. In the present study, we synthesize the results of independent studies examining the effect of ApoE on LVF development in thalassemic patients through a meta-analytic approach. However, all studies report more than one outcome, as patients are classified into three groups according to the severity of the symptoms and the genetic polymorphism. Thus, a multivariate meta-analytic method that addresses simultaneously multiple exposures and multiple comparison groups was developed. Four individual studies were included in the meta-analysis involving 613 beta-thalassemic patients and 664 controls. The proposed method that takes into account the correlation of log odds ratios (log(ORs)), revealed a statistically significant overall association (P-value = 0.009), mainly attributed to the contrast of E4 versus E3 allele for patients with evidence (OR: 2.32, 95% CI: 1.19, 4.53) or patients with clinical and echocardiographic findings (OR: 3.34, 95% CI: 1.78, 6.26) of LVF. This study suggests that E4 is a genetic risk factor for LVF in beta-thalassemia major. The presented multivariate approach can be applied in several fields of research.
Keyphrases
- end stage renal disease
- left ventricular
- systematic review
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- heart failure
- mitral valve
- acute myocardial infarction
- case control
- magnetic resonance imaging
- randomized controlled trial
- depressive symptoms
- cognitive decline
- pulmonary hypertension
- meta analyses
- coronary artery disease
- sickle cell disease
- type diabetes
- computed tomography
- data analysis
- physical activity
- acute coronary syndrome
- dna methylation
- air pollution
- genome wide
- percutaneous coronary intervention
- left atrial
- cardiac resynchronization therapy
- contrast enhanced